Seborrheic Dermatitis Completed Phase 4 Trials for Crisaborole (DB05219)

Also known as: Seborrhea / Seborrhoeic dermatitis / Dermatitis, Seborrheic / Seborrheic eczema / Dermatitis seborrheic / Dermatitis seborrhoeic / Eczema seborrhoeic / Seborrhoea / Seborrheic dermatitis, unspecified / Skin seborrhoeic / Seborrhoeic eczema / Seborrhoeic dermatitis, unspecified / Skin seborrheic

IndicationStatusPhase
DBCOND0036095 (Seborrheic Dermatitis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03567980A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic DermatitisTreatment